Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Alexandre Mebazaa(Université Paris Cité), Beth A. Davison(Momentum Research), Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Alain Cohen‐Solal(Assistance Publique – Hôpitaux de Paris), Rafael Díaz(Estudios Clínicos Latinoamérica), Gerasimos Filippatos(National and Kapodistrian University of Athens), Marco Metra(University of Brescia), Piotr Ponikowski(Wroclaw Medical University), Karen Sliwa(University of Cape Town), Adriaan A. Voors(University Medical Center Groningen), Christopher Edwards(Momentum Research), Maria Novosadova(Momentum Research), Koji Takagi(Momentum Research), Albertino Damasceno(Eduardo Mondlane University), Hadiza Saidu(Bayero University Kano), Étienne Gayat(Inserm), Peter S. Pang(Indiana University – Purdue University Indianapolis), Jelena Čelutkienė(Vilnius University), Gad Cotter(Momentum Research)
The Lancet
November 7, 2022
Cited by 989Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis